Richard L. Schilsky Cancer and Leukemia Group B
Achievement Award

The Alliance for Clinical Trials in Oncology Foundation invites nominations for the Richard L. Schilsky Cancer and Leukemia Group B Achievement Award each year.

The RLS CALGB Achievement Award was established in 2010 to recognize the 15-year tenure of Dr. Schilsky as Group Chair of Cancer and Leukemia Group B (CALGB). The award acknowledges the significant contributions of an individual to cooperative group research. As an organization, it is vital for the Alliance for Clinical Trials in Oncology to identify and honor the talented people responsible for its success. The award was made possible through generous donations from our members and industry supporters.

All Alliance members are welcome to submit nominations for this award.

Award recipients present lectures during the Plenary Session at the Alliance Fall Group Meeting held in November of each year.

The recipient of the 2020 Richard L. Schilsky Cancer and Leukemia Group B Achievement Award is Jeffrey J. Kirshner, MD, FACP, FASCO. Dr. Kirshner is Principal Investigator of Hematology Oncology Associates of Central New York and Director of Research for the HOACNY Community Clinical Oncology Program in New York. He also serves as Chair of the Alliance Data and Safety Monitoring Board and is a member of the Alliance Breast Committee, Alliance Symptom Intervention Committee, and Alliance Community Oncology Committee. Learn more about Dr. Kirshner here.


Past Award Recipients
2019 - Frances (Fran) Laurie
2018 - Gary W. Unzeitig, MD
2017 - Richard A. Larson, MD
2016 - Deborah Schrag, MD
2015 - Alan P. Lyss, MD
2014 - Nancy L. Bartlett, MD
2013 - Hyman B. Muss, MD
2012 - Clara D. Bloomfield, MD
2011 - Eric J. Small, MD
2010 - John C. Byrd, MD